Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma

AIM: To assess the efficacy and safety of a new treatment modality, cellular immune therapy based on personalized peptide vaccination (PPV-DC-CTL) combined with radiotherapy, for treating advanced hepatocellular carcinoma (HCC). METHODS: A total of nine patients with advanced HCC were enrolled. Mult...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Shen, Jie, Wang, Li-Feng, Zou, Zheng-Yun, Kong, Wei-Wei, Yan, Jing, Meng, Fan-Yan, Chen, Fang-Jun, Du, Juan, Shao, Jie, Xu, Qiu-Ping, Ren, Hao-Zhen, Li, Ru-Tian, Wei, Jia, Qian, Xiao-Ping, Liu, Bao-Rui
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2017
Assuntos:
Clinical Trials Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5550789/
https://ncbi.nlm.nih.gov/pubmed/28839440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i29.5395
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados